“Ozempic MDL Reassigned After Judge Pratter’s Unexpected Death”

The U.S. Judicial Panel on Multidistrict Litigation has reassigned the litigation involving Ozempic and similar drugs following the sudden death of U.S. District Judge Gene E.K. Pratter. Judge Pratter had been overseeing the multidistrict litigation (MDL) in the Eastern District of Pennsylvania. For more detailed information, the original report is available on Law360.